Kangmei Pharmaceutical announced that the company recently received first instance verdicts from the Guangzhou Intermediate Court on two claims disputes. The first is the lawsuit against Ma Xingtian, Xu Dongjin, and Qiu Xiwei. The amount involved was 2,608 million yuan, and Ma Xingtian and Xu Dongjin were judged to be compensated 1,396 million yuan, and Qiu Xiwei was liable for supplementary settlement within 142 million yuan; the second was the lawsuit against the Zhenzhong Pearl River case, which involved 341 million yuan, and ruled that Zhenzhong Pearl River was liable for supplementary settlement within 141 million yuan. Currently, the judgment has not entered into force and is pending appeal; subsequent effects are yet to be determined.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.